This 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.
American Diabetes Association (ADA) and Kidney Disease Improving Global Outcomes (KDIGO) emphasize the importance of comprehensive, patient-centered medical care for improved outcomes in patients.
Nonpharmaceutical strategies, such as lifestyle modifications, play a critical role in managing CKD associated with T2D.
ADA guidelines recommend diabetes self-management education and support (DSMES) for all individuals with diabetes.
Primary care clinicians play a critical role in the early identification and management of CKD and collaborative effort is needed to improve care of these patients.
This is episode 4 of a 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.
Drs. Radica Alicic (Internist and Clinical Professor at the University of Washington) and Jennifer B. Green (Endocrinologist and Professor of Medicine at Duke University Medical Center) emphasize the importance of patient-centered care, nonpharmaceutical strategies, and primary care clinicians' role in early CKD management, stressing collaboration to improve outcomes in T2D patients.
